Quick Answer
Harmony Biosciences Holdings, Inc. reported Operating Income of $208.47 million for fiscal year 2025.
Harmony Biosciences Holdings, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | $208.47M | +9.2% |
| 2024 | $190.83M | -0.6% |
| 2023 | $192.03M | +59.8% |
| 2022 | $120.19M | +37.3% |
| 2021 | $87.53M | +415.3% |
| 2020 | $16.99M | +111.6% |
| 2019 | -$145.90M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $65.49M | +6.1% | +35.9% |
| June 30, 2025 | $48.18M | +125.6% | -14.3% |
| March 31, 2025 | $56.24M | +8.1% | -8.9% |
| September 30, 2024 | $61.71M | -4.3% | +189.0% |
| June 30, 2024 | $21.36M | -54.5% | -59.0% |
| March 31, 2024 | $52.03M | +28.7% | -19.3% |
| September 30, 2023 | $64.51M | +442.0% | +37.5% |
| June 30, 2023 | $46.90M | +41.6% | +16.0% |
- Harmony Biosciences Holdings, Inc. showed an increase of +9.2% in Operating Income compared to the prior fiscal year.
- Over the 2019–2025 period, Harmony Biosciences Holdings, Inc.’s operating income has grown by 242.9% (from -$145.90 million to $208.47 million).
- The most recent figure is from Harmony Biosciences Holdings, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: